A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors

BACKGROUND: PEP02 (also known as MM-398, nal-IRI) is a novel nanoparticle formulation of irinotecan encapsulated in liposomes. The aims of this study were to investigate the dose-limiting toxicity (DLT), maximum tolerated dose (MTD) and pharmacokinetics (PK) of PEP02 in combination with 5-FU and LV,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Nai-Jung, Chao, Tsu-Yi, Hsieh, Ruey-Kuen, Wang, Cheng-Hsu, Wang, Yi-Wen, Yeh, C. Grace, Chen, Li-Tzong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117585/
https://www.ncbi.nlm.nih.gov/pubmed/27871319
http://dx.doi.org/10.1186/s12885-016-2933-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117585/
https://www.ncbi.nlm.nih.gov/pubmed/27871319
http://dx.doi.org/10.1186/s12885-016-2933-6

Ejemplares similares